Health

The National Botanical Research Institute (NBRI), a Lucknow-based constituent laboratory of the Council of Scientific and Industrial Research (CSIR), is known for its research and development related to various botanical disciplines. A broad spectrum of research activities is being conducted at CSIR-NBRI, which includes plant diversity, systematics and herbarium, pharmacognosy, phytochemistry, plant ecology, environmental technologies, molecular biology, biotechnology, plant genetic resources, plant conservation, and agro-technologies.

Diphtheria is a highly contagious infection. It can affect the nose and throat, and sometimes the skin. If left untreated it can prove fatal. In high-income countries, all babies are vaccinated against the infection. However, in low- and middle-income countries, the disease can still cause sporadic infections or outbreaks in unvaccinated and partially-vaccinated communities.

The rollout of the Covid-19 vaccines by India in collaboration with leading global institutions has “rescued the world” from the deadly coronavirus and the contributions by the country must not be underestimated, a top American scientist has said.

Council of Scientific & Industrial Research (CSIR)’s constituent laboratories have been working relentlessly in partnership with industry to launch repurposed drugs through process development and conducting clinical trials. CSIR labs have also extensively contributed towards the launching of diagnostic kits including Feluda and Dry Swab Direct RT-PCR method for the screening of SARS-CoV-2.

India’s total Active Caseload stands at 1.68 lakh (1,68,358) today as the country added 12,286 new cases in the last 24 hours. The country’s present active caseload now consists of 1.51% of India’s total Positive Cases.

While addressing the audience Dr Singh said that the commencement of session of first batch of MBBS students at GMC, Doda was a historic achievement since it fulfilled the aspirations of the people and would lead to medical and educational advancement of people of the region.

India will start administering Covid-19 vaccines to two more priority groups — those above 60 years and those aged above 45 years with comorbidities — from 1 March onwards, Union Information and Broadcasting Minister Prakash Javadekar said at a press briefing Wednesday where he announced decisions taken by the Cabinet at a meeting earlier.

“Our Ayush network has performed incredibly well in Covid times, not just to boost immunity but also for scientific research. Ayush infrastructure has helped the country a lot. Along with Indian drugs and vaccines our spices and ‘kadas’ have contributed immensely and the world is experiencing their benefits. Our traditional medicine has made a place on the world stage,” the PM said on Tuesday as he interacted with stakeholders on health budget provisions which he described as unprecedented.